Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

globenewswire.com - Zealand Pharma - Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
GlobeNewswire

Company announcement – No. 9 / 2026 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons Copenhagen, Denmark, April 22, 2026 –…

globenewswire.com - NETRIS Pharma - NETRIS Pharma: Nature publishes positive pancreatic cancer Phase 1b data for NP137 anti-netrin-1 monoclonal antibody
NETRIS Pharma: Nature publishes positive pancreatic cancer Phase 1b data for NP137 anti-netrin-1 monoclonal antibody
GlobeNewswire

LAPNET-01 Phase 1b study shows netrin-1 blockade may overcome and prevent chemoresistance in patients with pancreatic ductal adenocarcinoma (PDAC) with locally advanced PDAC (LAPC) NP137 is the first-in-class anti-netrin-1 monoclonal antibody (mAb)…

globenewswire.com - Orion Oyj - Orion Pharma initiates TEADCO Phase 1b/2 basket trial evaluating ODM-212 in combination with standard of care treatments in patients with select advanced solid tumours
Orion Pharma initiates TEADCO Phase 1b/2 basket trial evaluating ODM-212 in combination with standard of care treatments in patients with select advanced solid tumours
GlobeNewswire

Orion Pharma initiates TEADCO Phase 1b/2 basket trial evaluating ODM-212 in combination with standard of care treatments in patients with select advanced solid tumours Orion Corporation (Orion Pharma) today announced the initiation of a Phase 1b/2…

fool.com - James Halley - Should You Forget Pfizer and Buy This Pharma Stock Instead?
Should You Forget Pfizer and Buy This Pharma Stock Instead?
The Motley Fool

Pfizer (PFE 1.68%) and AbbVie (ABBV 1.20%) are two pharmaceutical giants that seem to be headed in opposite directions. Pfizer's stock is up by more than 10% this year, while AbbVie's shares have fallen more than 7%. But when you look at their…

axios.com - Zachery Eanes - Pharma giant AbbVie plans $1.4 billion campus near Research Triangle Park
Pharma giant AbbVie plans $1.4 billion campus near Research Triangle Park
Axios

AbbVie, a biopharmaceutical giant, will invest $1.4 billion into a new facility in Durham, the company and the N.C. Department of Commerce announced Wednesday. Why it matters: The expansion is yet another win from the pharmaceutical industry for…

statnews.com - Katie Palmer - Will bargain-basement telehealth visits help pharma drive drug scripts?
Will bargain-basement telehealth visits help pharma drive drug scripts?
STAT

The little pink pill recently got a retail boost. Addyi, a drug that treats low libido in premenopausal women, has been on the market for more than a decade after a controversial approval. But in December the Food and Drug Administration expanded…

thehindubusinessline.com - Pharma lifts Nifty off lows as crude oil, geopolitics keep markets under pressure at midday
Pharma lifts Nifty off lows as crude oil, geopolitics keep markets under pressure at midday
BusinessLine

Markets were trading sharply lower at midday on Friday, April 23, 2026, though selective buying in pharma and energy stocks helped indices recover from their worst levels of the session. The BSE Sensex was down ₹710.66 or 0.91 per cent at…

pymnts.com - Tom Ostrosky - Amazon Targets the GLP-1 Gap Big Pharma Left Open
Amazon Targets the GLP-1 Gap Big Pharma Left Open
PYMNTS.com | Breaking News, Trends and Analysis

Amazon built one system to handle all of it. Through its One Medical arm, the company launched a GLP-1 Management Program bundling clinical screening, prescriptions, ongoing supervision and pharmacy delivery into a single offering. The program…

forbes.com - Tim Walsh - 3 Air Quality Myths Costing Your Lab Money And Safety
3 Air Quality Myths Costing Your Lab Money And Safety
Forbes

Air quality in life science labs isn't the kind of topic that grabs headlines. It can't compete with breakthrough Alzheimer's treatments or the next‑generation immunotherapies transforming oncology and yet, it's what they hinge on. Behind…

marketbeat.com - Ascendis Pharma A/S (ASND) Expected to Announce Quarterly Earnings on Thursday
Ascendis Pharma A/S (ASND) Expected to Announce Quarterly Earnings on Thursday
MarketBeat

Ascendis Pharma A/S (NASDAQ:ASND - Get Free Report) is projected to announce its Q1 2026 results after the market closes on Thursday, April 30th. Analysts expect the company to announce earnings of $0.33 per share and revenue of $376.1140 million…

marketbeat.com - M&T Bank Corp Takes Position in BridgeBio Pharma, Inc. $BBIO
M&T Bank Corp Takes Position in BridgeBio Pharma, Inc. $BBIO
MarketBeat

M&T Bank Corp purchased a new stake in BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm purchased 388,019 shares of the company's stock, valued at…

forbes.com - Jack McCullough - Atsushi Kitamura : Leading With Reality, Discipline, And Courage
Atsushi Kitamura : Leading With Reality, Discipline, And Courage
Forbes

Atsushi Kitamura, CFO of Astellas Pharma, oversees finance for one of Japan's leading global pharmaceutical companies. Atsushi Kitamura is the CFO of Astellas Pharma, a global life sciences company committed to turning innovative science into VALUE…

swissinfo.ch - Aylin Elçi - From Covid to Hormuz, what has Switzerland learned about drug shortages?
From Covid to Hormuz, what has Switzerland learned about drug shortages?
www.swissinfo.ch

Suiza ante un suministro frágil de medicamentos en plena crisis internacional Cadeias globais em crise ameaçam remédios essenciais na Suíça بين كوفيد…

seekingalpha.com - Albert Anthony - Sun Life Remains A Bright Spot In A Volatile Market, Despite Elevated Valuation (NYSE:SLF)
Sun Life Remains A Bright Spot In A Volatile Market, Despite Elevated Valuation (NYSE:SLF)
Seeking Alpha

Albert Anthony is the pen name of a business author on Amazon and his newest book is 'How To Pick Stocks: 8 Steps For Long-Term Investing with Fundamental & Technical Analysis,' now available as a 2026 edition paperback and Kindle ebook in several…

rediff.com - Nandita Malik - Indian Stock Markets Slump: Crude Oil Jumps Over $100, US-Iran Tensions Escalate
Indian Stock Markets Slump: Crude Oil Jumps Over $100, US-Iran Tensions Escalate
Rediff.com

Indian stock markets, including the Sensex and Nifty, witnessed a significant slump in early trade as Brent crude oil prices surged past the $100 per barrel mark, fuelled by stalled US-Iran negotiations and escalating geopolitical tensions in the…

Receive a Daily briefing on Pharma Industry News

Get Started